Replies to post #9970 on ScripsAmerica Inc. (SCRCQ)

[Bsav88atty]

Cats - Your points are well taken, as many were described in the link to the Kline study that I posted insofar as SCRC is looking to market RapidMeds in the generics space. But it seems that it could use it best in class technology to differentiate it from the other children's pain relief meds and demand a higher price.

By the way, which OTC launches have you worked on without tv advertising and how did each do in their first couple years?

Thanks!

Bsav

[Guts]

I agree with you Cats. Being that we are both in the pharma business we know products can and do success without TV ads. The profit margin on generic and OTC products is so small, I really don't think we'll see TV ads. What I do know is wholesale distributors usually pay their Reps on commission. These Reps will create shelf space, shelf space creates awareness, awareness creates purchasing, and yes purchasing creates REVENUES. And the topic of brand name versus generic, yes years ago that agrument swayed in the branded drug way. But today the image of generic drugs has changed in a postive light. Consumers know they can purchase a highly effective products at a good price without always seeking out a brand named product. Besides, we don't need 100% of the market, 5% of a multi-billion market will drive so much revenue we won't know what to do with ourselves. Bsav made some good points but I believe Bob Schniedermam, the CEO, is on top of everthing. I will let Bob do the thinking and planning, I'll just worry about buying the stock and building my SCRC portfolio. Go SCRC!!!